Ignite Creation Date:
2024-05-06 @ 3:49 PM
Last Modification Date:
2024-10-26 @ 1:57 PM
Study NCT ID:
NCT04762498
Status:
COMPLETED
Last Update Posted:
2024-05-13
First Post:
2021-02-12
Brief Title:
A Phase 4 Open-label Study of KRYSTEXXA Pegloticase Co-administered With Methotrexate MTX in Patients With Uncontrolled Gout FORWARD OL
Sponsor:
Organization:
Amgen